Help us research an investigational medication for rheumatoid arthritis.

Together, we can research an investigational medication that is designed to work in a different way.

The contRAst-2 Study will help us learn more about an investigational medication with a different mechanism of action (way of working) for people with rheumatoid arthritis (RA). The study will help determine whether the investigational medication works and how safe it is for people with RA whose current treatment with conventional synthetic disease-modifying anti-rheumatic drugs (csDMARDs) is not working well enough.

Are you able to help?

You may be eligible for the contRAst-2 Study if you:
• are 18 years of age or older
• have been diagnosed with rheumatoid arthritis
• have swollen and painful joints despite taking one or more csDMARD for the past 12 weeks.

The study will last for up to 1 year and 3 months. There may also be the option to continue on a long term extension study.
Please contact the study team today if you are interested in joining the contRAst-2 Study or would like more information. By contacting us, you are under no obligation to take part in the study. We look forward to hearing from you.

Find out more at www.contrastraprogram.com

Contact the research team

Melanie Aikebuse Tel: 07 5552 7260 or Donna Reeves Tel: 07 5678 0350 Email: [email protected]